Unsurprising reaction, revenue growth slowing and what looks like a failure on the therapy when compared to the currently approved therapy drug
The base was always suspect to me with that nasty selling bar in the middle of it on the last quarterly, topping bases always have large selling bars within them
Ann: Q3 2023 Business Update to Accompany Quarterly Results, page-52
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$24.03 |
Change
0.210(0.88%) |
Mkt cap ! $8.131B | |||
| Open | High | Low | Value | Volume |
| $23.84 | $24.22 | $23.62 | $21.07M | 881.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $24.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $24.05 | 5912 | 3 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| TLX (ASX) Chart |